Stroke, Vol 19, 223-227, Copyright © 1988 by American Heart Association
PD Lyden, LI Alving, JA Zivin and JF Rothrock
Newly developed colloid volume-expanding agents with mean molecular weights
lower than currently available agents may improve outcome after stroke with
fewer allergic and coagulation system side effects. The smaller molecule,
however, may exacerbate ischemic cerebral edema if it accumulates in areas
where ischemia has damaged the blood-brain barrier. We administered
low-molecular-weight hydroxyethyl starch to rabbits after embolic
infarction and measured specific gravity and total water content. We found
evidence of ischemic edema in the hemisphere ipsilateral to the embolic
arterial occlusion, but the measures of edema were not different in treated
and control groups. Of those rabbits suffering severe neurologic deficit,
mortality was 2 of 13 in the treated compared with 7 of 12 in the control
groups (p less than 0.01). Thus, hemodilution with low-molecular-weight
hydroxyethyl starch did not exacerbate cerebral edema and may have improved
survival in this model.
ARTICLES
Hemodilution with low-molecular-weight hydroxyethyl starch after experimental focal cerebral ischemia in rabbits
Department of Neurology, Veterans Administration Medical Center, San Diego, CA 92161.
This article has been cited by other articles:
![]() |
S. S. Kaplan, T. S. Park, E. R. Gonzales, J. M. Gidday, and J. A. Zivin Hydroxyethyl Starch Reduces Leukocyte Adherence and Vascular Injury in the Newborn Pig Cerebral Circulation After Asphyxia Editorial Comment Stroke, September 1, 2000; 31(9): 2218 - 2223. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |